A new study from the Journal of Addictive Diseases is highlighting one way that people are trying to cope with the stressful situation of the Covid-19 pandemic- using cannabis.
Category: Vices
Psychedelic Drug Company MindMed Applies For Nasdaq Up-Listing
If approved, MindMed could become the second psychedelic drug development company listed on Nasdaq.
Michigan’s Cannabis Demand Outpaces Supply-High Life Farms Alleviates Shortage
Despite only coming online last December, Michigan’s recreational market is growing at a record pace and is on track to generate between $400 million to $475 million in sales in 2020 alone.
Unlike Opioids, Chronic Cannabis Use Doesn’t Lead To Heightened Pain Sensitivity
Could cannabis be a more attractive alternative for chronic pain relief? A new study suggests that cannabis, unlike opioids, doesn’t lead to heightened pain sensitivity over time.
5 Moving Questions With Founder & CEO Of Haleigh’s Hope, Jason Cranford
In 2009 I was made aware of a license that was being proposed to cultivate and distribute medical cannabis in the State of Colorado and I decided to move there from Atlanta, GA to be one of the nation’s first legal cannabis producers.
5 Probing Questions For BLLRDR Cannabis And Jef Tek
I firmly believe I could not do what I do without the enrichment good music brings to my life and I’d like to think that maybe, just maybe, there are some artists out there that will get to experience BLLRDR and that it will inspire them to make even b…
Former Actavis Head Of M&A Joins Psychedelics Company As CEO
In an exclusive conversation, pharma veteran Doug Drysdale revealed he has joined psychedelics-focused life sciences company Cybin Corp. as CEO.
Etain Health Manhattan, Bringing Subtle Design To The Art Of Medical Cannabis
Sophisticated and inviting, the new Midtown East location is only a block from Sutton Place on the iconic Designers Way, and welcomes medical marijuana patients and retail customers to enjoy experiential interactions and integrative wellness offerings.
Synthetic Cannabinoid Drug For Covid-19 Approved For Phase-1 Clinical Trials
In recent months, some have pointed to cannabis as a possible treatment for severe cases of the Covid-19 – pointing specifically towards the cannabinoid CBD. Now, a synthetic cannabinoid drug, ARDS-003, has been given approval by the FDA to begin phase…
First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans
A new series of clinical trials will look into psilocybin for the treatment of posttraumatic stress disorder (PTSD) in veterans. It is believed to be the first of its kind.
